Contact us if you or a loved one is interested in a new study with a new investigational product aimed at reducing respiratory exacerbations in former smokers with COPD.
Study will include 16 In-Person Visits and 16 Phone calls over a 77 Week period.
Study drug will be administered subcutaneously every 2-4 weeks.
To Qualify:
-Be 40 to 85 years of age
-Diagnosed with COPD for at least 1 year
-Smoking history of greater than 10 pack-years
-Not active smoker